US FDA approves BeOne's drug for a type of blood cancer
- Posted on May 13, 2026
- By Bing News
- 0 Views
- 1 min read
US FDA approves BeOne's drug for a type of blood cancer
By Siddhi Mahatole and Puyaan Singh May 13 (Reuters) - BeOne Medicines said on Wednesday that the U.S. Food and Drug Administration had approved its drug for a type of blood cancer. The drug, branded as Beqalzi, was greenlit to treat relapse or refractory mantle cell lymphoma, an aggressive cancer of the lymphatic system, which contains disease-fighting white blood cells that relapses after
